A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

This study has been withdrawn prior to enrollment.

(Study was cancelled before patient enrollment)

Sponsor:

Information provided by:

Arog Pharmaceuticals LLC

ClinicalTrials.gov Identifier:

NCT00386555

First received: October 6, 2006

Last updated: August 7, 2012

Last verified: May 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given